Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins
- 1 November 1984
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 94 (11) , 1407-1410
- https://doi.org/10.1288/00005537-198411000-00001
Abstract
Monocytes from patients with head and neck cancer produce excessive PGE2 which seems to be associated with decreased lymphoproliferation in vitro. This may be a pathological exaggeration of a normal homeostatic mechanism. It is speculated that a stimulus for excessive PGE2 production could be immune complexes. Although PGE2 suppresses many important immune processes relevant for neoplasia, it can also have complex and diverse effects on tumor cells. Caution should be exercised with human trials of prostaglandin synthetase inhibitors such as indomethacin.Keywords
This publication has 20 references indexed in Scilit:
- Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapyCancer, 1982
- Relationship of the suppression of macrophage mediated tumor cytotoxicity in conjunction with secretion of prostaglandin from the macrophages of breast cancer patientsInternational Journal of Immunopharmacology, 1982
- The effect of Fc fragments of IgG on human mononuclear cell responsesCellular Immunology, 1980
- Immune-complex induced prostaglandin production by monocytes of normal human subjects and cancer patientsProstaglandins and Medicine, 1980
- High-affinity binding sites for prostaglandin E on human lymphocytesCellular Immunology, 1979
- Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cellsCellular Immunology, 1978
- Deficient cell‐mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cellsThe Laryngoscope, 1978
- Prostaglandin-Producing Suppressor Cells in Hodgkin's DiseaseNew England Journal of Medicine, 1977
- Defective recognitive immunity in family aggregates of colon carcinoma.Journal of Clinical Investigation, 1977
- Facilitation or attenuation of mixed leukocyte culture responsiveness by adherent cellsNature, 1976